AIMIL Pharmaceuticals, a science-driven Ayurveda company that strives toward establishing a disease-free and healthy society, has announced its strategic expansion in the international markets. The company aims to expand its operations into 25 countries, including Europe, the CIS region, the Middle East, Africa, and the Indian Ocean islands.
AIMIL has emerged as one of the fastest-growing pharmaceutical companies in its segment with multiple achievements including hitting the mark of Rs 500 crores revenue in the last financial year. The company’s vision was conceptualized by its Founder & Managing Director Shri K.K.Sharma in the year 1984, since then Aimil is providing solutions to tough diseases like CKD, Diabetes, and Vitiligo through innovation & research.
The group entered the personal care space with 60 products under the 'Aimil Ayouthveda' banner in 2020 and is actively working to get a strong foothold in the veterinary segment with its Aimil Vet & Pet division. AIMIL has also achieved the 2nd spot in the tally of herbal pharma companies & got featured in the top-100 of all pharma companies in India.
Speaking on the expansion activities, Dr. Ikshit Sharma, Director of AIMIL Pharmaceuticals said, "This expansion plan is in line with the ever-increasing global demand for authentic science-based ayurvedic products for better health. Our products with ECOCERT-certified organic herbs would ensure the delivery of premium quality, safe and result-oriented products across various categories such as healthcare, personal care, wellness, and veterinary sectors."
"We aim to introduce more innovative products as per markets' need and target 100 countries in the next two financial years. We have also constituted a team headed by Mr. Amit Dixit, Global CEO to enhance our focus on international business and expect to generate a revenue of USD 15 million from this vertical in the next five years," he added.